France
SUBSTIPHARM, founded in 1995, is a France-based pharmaceutical group that brings a Global vision with a Local approach. As a privately held company, SUBSTIPHARM has built a formidable reputation in the Manufacturing and Pharmaceutical industries.
With its expansive portfolio, SUBSTIPHARM distinguishes itself through the development, supply, and commercialization of pharmaceuticals across more than 90 countries. They possess a robust array of over 90 different molecules that are either licensed out or distributed, backed by a strong pipeline of more than 50 ongoing projects.
Their successful product lineup includes mature brands, generics, over-the-counter (OTC) pharmaceuticals, and biologics such as vaccines. The company has a particular emphasis on developing difficult-to-make medicines and value-added presentations.
Given SUBSTIPHARM's existing scale and strong market presence, their lack of recent investment could denote robust independence and self-sufficiency, signaling stability to potential investors.
Tiefenbacher Group